new glp 1 med Considering Starting on a GLP-1? What You Need to Know Comparing Ozempic, Wegovy and Other

In August 2025, semaglutide (Wegovy) received FDA accelerated approval for MASH with F2 to F3 fibrosis based on the results of the ESSENCE trial

As a qualified Nutritionist, Certified Fitness Trainer, and Lifestyle Coach, Ive helped clients transform their health with personalized plans that are enjoyable, sustainable and effective

Funds are available on the first of each month

To report any suspected adverse reactions to compounded semaglutide, contact the FDA at 1-800-FDA-1088 or visit FDA MedWatch

[28] [9] Close collaboration between gastroenterology and endocrinology or diabetes specialists is advisable

Several GLP-1 receptor agonists are currently available through the NHS and private prescriptions in the UK, each with distinct characteristics regarding administration, efficacy, and gastrointestinal tolerability